Skip to content
MEDIUM
Administrative manufactura

Pharmaceutical companies to implement electronic medication registration by March

BOE-A-2026-12611

Prepared and reviewed by the BMC editorial team  ·  Methodology Published 11 Jun 2026, 19:22

Technical details

Type
Royal Decree (what is this?)
Identifier
BOE-A-2026-12611
Published
11 Jun 2026
Entry into force
11 Jul 2026 · in 5 days

Summary

Royal Decree 468/2026 amends RD 1345/2007 to require electronic registration of industrially produced human medicines. A new Additional Provision 7 sets a three-month implementation period from the decree's entry into force, aiming to modernise control and improve product traceability (arts. 81.1, 84-86, disp. ad. 7).

Lifecycle

2026-06-11PublishedPublished in the BOE
2026-07-11Into forceComes into force (disposicion final segunda)

BMC resources for this provision

Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The administrative team reviews your specific situation.

Talk to the administrative team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact